Search research articles
Contact Us
Filters
Showing results (111-120 of 208) with videos related to
Page
of 21
Sort By:
Journal for Immunotherapy of Cancer
|
July 13, 2018
Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)
Paolo A Ascierto, James Brugarolas, Luigi Buonaguro, et al.
The Journal of Molecular Diagnostics : JMD
|
October 25, 2017
Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid Tumors
Jeffrey M Conroy, Sarabjot Pabla, Sean T Glenn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2008
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group
David F McDermott, Jeffrey A Sosman, Rene Gonzalez, et al.
Journal of Translational Medicine
|
November 5, 2017
The need for a network to establish and validate predictive biomarkers in cancer immunotherapy
Giuseppe V Masucci, Alessandra Cesano, Alexander Eggermont, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 7, 2016
Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma
Dirk Schadendorf, Reinhard Dummer, Axel Hauschild, et al.
Circulation. Heart Failure
|
April 18, 2018
Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma
Anna B Catino, Rebecca A Hubbard, Julio A Chirinos, et al.
Journal for Immunotherapy of Cancer
|
October 28, 2025
Genetic haplotypes in <i>VWA8, OSBPL6,</i> and <i>ADAMTS9-AS2</i> are associated with immune-related adverse effects in ICI-treated patients with cancer
Prithvi Raj, Jialiang Liu, Chengsong Zhu, et al.
Journal of Translational Medicine
|
January 7, 2021
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge" (December 4th-5th, 2019, Naples, Italy)
Paolo A Ascierto, Lisa H Butterfield, Katie Campbell, et al.
Cell Stem Cell
|
June 15, 2024
Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells
Jason S Kirk, Jie Wang, Mark Long, et al.
Biorxiv : the Preprint Server for Biology
|
March 22, 2023
Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells
Jason S Kirk, Jie Wang, Amanda Tracz, et al.
Page
of 21
Search research articles
Search
Showing results (111-120 of 208) with videos related to
Sort By:
Page
of 21
Journal for Immunotherapy of Cancer
|
July 13, 2018
Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)
Paolo A Ascierto, James Brugarolas, Luigi Buonaguro, et al.
The Journal of Molecular Diagnostics : JMD
|
October 25, 2017
Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid Tumors
Jeffrey M Conroy, Sarabjot Pabla, Sean T Glenn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2008
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group
David F McDermott, Jeffrey A Sosman, Rene Gonzalez, et al.
Journal of Translational Medicine
|
November 5, 2017
The need for a network to establish and validate predictive biomarkers in cancer immunotherapy
Giuseppe V Masucci, Alessandra Cesano, Alexander Eggermont, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 7, 2016
Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma
Dirk Schadendorf, Reinhard Dummer, Axel Hauschild, et al.
Circulation. Heart Failure
|
April 18, 2018
Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma
Anna B Catino, Rebecca A Hubbard, Julio A Chirinos, et al.
Journal for Immunotherapy of Cancer
|
October 28, 2025
Genetic haplotypes in <i>VWA8, OSBPL6,</i> and <i>ADAMTS9-AS2</i> are associated with immune-related adverse effects in ICI-treated patients with cancer
Prithvi Raj, Jialiang Liu, Chengsong Zhu, et al.
Journal of Translational Medicine
|
January 7, 2021
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge" (December 4th-5th, 2019, Naples, Italy)
Paolo A Ascierto, Lisa H Butterfield, Katie Campbell, et al.
Cell Stem Cell
|
June 15, 2024
Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells
Jason S Kirk, Jie Wang, Mark Long, et al.
Biorxiv : the Preprint Server for Biology
|
March 22, 2023
Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells
Jason S Kirk, Jie Wang, Amanda Tracz, et al.
Page
of 21